
66-22-8
Product No.:SA11
CAS No.:66-22-8
Synonyms:2,4-Pyrimidinediol;2,4-Dihydroxypyrimidine;2,4(1H,3H)-Pyrimidinedione
Formular:C4H4N2O2
Molecular weight:112.09
Description
Technical Parameters
Uracil
Synonym:Pyrimidine-2,4(1H,3H)-dione;Uracil;2-Oxy-4-oxypyrimidine;COATED SAFETY BOTTLE 2,5LWITHOUT CAP ISO;ALUMINIUM CAN WITH HANDLE AND STOPPER;hybarx;2,4(1H,3H)-Pyrimidinedione;Uracyl;2,6-Dihydroxypyrimidine;4-Hydroxy-2(1H)-pyrimidinone;2,4-DihydroxypyrimidineHybar X;2,4-Pyrimidinediol;Pirod
Specifications
|
Description |
White or almost crystalline powder |
|
Identification |
Confirm with IR standard |
|
Purity |
≥98.00% |
|
Loss on drying |
≤0.5% |
|
Residue on ignition |
≤0.1% |
|
Heavy Metals |
≤20ppm |
Application
Uracil is an organic base and one of the four major bases in RNA.
As a key pyrimidine component of ribonucleic acid, it is a constituent of various uridine nucleotides.
Uracil links with ribose to form uridine, and its triphosphate form (UTP) acts as a precursor for RNA biosynthesis and a coenzyme in sugar synthesis.
Uracil inhibits the degradation of tegafur, raises fluorouracil levels, and strengthens its anticancer activity.
It has similar clinical indications to fluorouracil, and is mainly used for digestive system cancer, breast cancer and thyroid cancer.
Combined with mitomycin, it exhibits favorable efficacy against advanced gastric cancer.
It is used as a pharmaceutical intermediate and agricultural fertilizers.
Uracil Price
| Uracil 1kg | $45.0/kg | on stock |
| Uracil 100kg | $27.5/kg | on stock |
| Uracil 1000kg | $25.5/kg | on stock |
| Uracil 10MT | $25.5/kg | on stock |
Customized manufacture – Metal Control
Pb, Cd, Hg, As, Cr, Fe, Cu, Zn, Ni, Co, Mn
Customized manufacture – Impurity Control
5-Methoxy uracil ≤0.15%
Other single impurity ≤0.3%
Total impurities ≤1.0%
route of synthesis

Other Information
Storage:Room temprature, tightly closed, protected from humidity.
Package:10g/bag,100g/bag,1kg/bag,5kg/drum,25kg/drum.
Drum packing: 2 plastic PE bags innerside + paper drum outside.
Send Inquiry







